Evidence map›Paper›PMID 31134099›Full record

ReviewFrontiers in immunology2019

Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.

Rebekah Honce, Stacey Schultz-Cherry

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 270 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
270citing papers in PubMed, 1 pooled it
47.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04480034 unknown statusnot on this mapstarted 2020, after this paper: background citation

Laparoscopic Bariatric Surgery During Phase 2-3 Covid-19 Pandemic in Italy: a Multicenter, Prospective, Observational Study.

TypeobservationalSponsorUniversity of Roma La SapienzaRan2020 to 2021Enrolled1,600ConditionsBariatric Surgery Candidate, Covid19, Complication of Surgical Procedure, Pneumonia, ViralArmsBariatric procedures
NCT04617119 naunknown statusnot on this mapstarted 2020, after this paper: background citation

The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU: A Pilot Study

TypeinterventionalSponsorDR. JASSIM ALGHAITHRan2020 to 2021Enrolled38ConditionsCovid19, Severe Systemic Illness Respiratory Muscle FatigueArmsThreshold IMT device, Conventional physical therapy
3 · Its place in the literature

Who cites it

270 citing papers in PubMed, 1 synthesis or guideline pooled it, 452 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Metabolic Syndrome Is Associated With Increased Risk ofOpen forum infectious diseases · 2026
    Article
  8. Article
  9. T cell dysregulation and remodeling in pediatric obesity and weight loss.bioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Update on the Efficacy of Vaccination on Host Immunity to Influenza Virus Infection.International archives of allergy and immunology · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

210 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Rebekah HonceDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, United States.
Stacey Schultz-CherryDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, United States.
St. Jude Children's Research Hospital · USUniversity of Tennessee Health Science Center · US

Funding

NIAID NIH HHS HHSN272201400006C
6 · The paper itself

Abstract

With the rising prevalence of obesity has come an increasing awareness of its impact on communicable disease. As a consequence of the 2009 H1N1 influenza A virus pandemic, obesity was identified for the first time as a risk factor for increased disease severity and mortality in infected individuals. Over-nutrition that results in obesity causes a chronic state of meta-inflammation with systemic implications for immunity. Obese hosts exhibit delayed and blunted antiviral responses to influenza virus infection, and they experience poor recovery from the disease. Furthermore, the efficacy of antivirals and vaccines is reduced in this population and obesity may also play a role in altering the viral life cycle, thus complementing the already weakened immune response and leading to severe pathogenesis. Case studies and basic research in human cohorts and animal models have highlighted the prolonged viral shed in the obese host, as well as a microenvironment that permits the emergence of virulent minor variants. This review focuses on influenza A virus pathogenesis in the obese host, and on the impact of obesity on the antiviral response, viral shed, and viral evolution. We comprehensively analyze the recent literature on how and why viral pathogenesis is altered in the obese host along with the impact of the altered host and pathogenic state on viral evolutionary dynamics in multiple models. Finally, we summarized the effectiveness of current vaccines and antivirals in this populations and the questions that remain to be answered. If current trends continue, nearly 50% of the worldwide population is projected to be obese by 2050. This population will have a growing impact on both non-communicable and communicable diseases and may affect global evolutionary trends of influenza virus.

Indexed as

AnimalsAntibodies, ViralDisease Models, AnimalHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesLungMiceMice, Inbred C57BLMice, ObeseObesityOrthomyxoviridae InfectionsRisk FactorsAntibodies, ViralInfluenza Vaccinesevolutionimmunityinfluenzaobesitypathogenesis

Identifiers

PMID31134099
PMCPMC6523028
OpenAlexW2944462720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.